Tijaria Polypipes per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−₹0.62−₹0.45−₹1.90−₹1.02−₹3.30
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−₹0.62−₹0.45−₹1.90−₹1.02−₹3.30
−₹11.80−₹11.80−₹11.35−₹9.46−₹8.44
₹0.00₹0.00₹0.00₹0.05₹4.84
—₹1.75−₹1.80₹1.36−₹1.86
₹1.75₹1.75−₹1.80₹1.36−₹1.86
2.92.92.92.92.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

TIJARIA₹5.00

Tijaria Polypipes Limited

· Capital Goods & Defence
₹ CrorePeersJISLDVREQSTEXMOPIPESTAINWALCHMKRITIPREMIERPOLJAICORPLTDJISLJALEQSMcap ₹14.3 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-3.30-1.02-1.90-0.45-0.62
Diluted EPS-3.30-1.02-1.90-0.45-0.62
Book Value per Share-8.44-9.46-11.35-11.80-11.80
Revenue per Share4.840.050.000.000.00
Cash Flow per Share-1.861.36-1.801.75—
Free Cash Flow per Share-1.861.36-1.801.751.75
Shares Outstanding (cr)2.92.92.92.92.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.